Metraipolis › archive › dc_0f495cc94f80
A Dual-Mechanism Targeted Cross-Convergence Prodrug Activation Strategy Enabled by Biological Stimulus Amplification toward Precision Cancer Therapy — Europe PMC PMID:42170190
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42170190
- DOI
- 10.34133/bmr.0328
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T14:08:42.435Z
- SHA-256 of the archived text
360425f4f975d045c5975d6a777d75ba028baa474dd876a5e2bddbe8fe485692- Stable URL of this page
https://metraipolis.com/documento/dc_0f495cc94f80
How to cite
A Dual-Mechanism Targeted Cross-Convergence Prodrug Activation Strategy Enabled by Biological Stimulus Amplification toward Precision Cancer Therapy — Europe PMC PMID:42170190 — Europe PMC (en), https://europepmc.org/article/MED/42170190 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0f495cc94f80 (Metraipolis archive dc_0f495cc94f80, sha256 360425f4f975d045c5975d6a777d75ba028baa474dd876a5e2bddbe8fe485692)
BibTeX
@misc{dc0f495cc94f80,
title = {A Dual-Mechanism Targeted Cross-Convergence Prodrug Activation Strategy Enabled by Biological Stimulus Amplification toward Precision Cancer Therapy — Europe PMC PMID:42170190},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42170190},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0f495cc94f80; sha256 360425f4f975d045c5975d6a777d75ba028baa474dd876a5e2bddbe8fe485692},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42170190. Agents can read the archived copy with the MCP tool read_document.